Personal information

Keywords

Epidemiology, Observational study, RWD analysis (Therapeutic area: Inflammation & Immunology)

Countries

Japan

Biography

(My job histroy)
I am working as medical writer for helthier world. I have been working in pharmaceutical industry from 2000. I started my career as business division staff, and since then I contributed to planning and operation of post marketing study (PMS) in compliance with Japanese pharmaceutcal regulations. From 2018, as medical writer for post marketing regulatory documents, I have been developing some documents which should be submittted to Pharmaceuticals and Medical Devices Agency in Japan.
(My expertise)
My expertise are epidemiology, observational study, and real-world data analysis (therapeutic area: Inflammation & Immunology). It is worthy that I had been in charge of biologics and Janus kinase inhibitors as business division staff and as PMS lead, in Inflammation & Immunology area.
As medical writer, I am now in charge of developing final reports based on PMS results of pharmaceutical drugs, vaccines, and biosimilars, in areas such as inflammation & immunology, oncology, and prophyractic vaccine and treatment drug for COVID-19.
I am also conducting research using my expertise for healthier world.

Activities

Collapse all

Employment (4)

Pfizer (Japan): Tokyo, JP

2014-10-01 to present (Medical Writing, Portofolio & project Management, R&D)
Employment
Source: Self-asserted source
Mihoko Yabuuchi

AbbVie (Japan): Tokyo, JP

2013-08-01 to 2014-09-30 (Business Division （Inflamation ＆Immunology）)
Employment
Source: Self-asserted source
Mihoko Yabuuchi

GlaxoSmithKline Japan: Tokyo, JP

2010-02-01 to 2013-07-31 (PMS,R&D)
Employment
Source: Self-asserted source
Mihoko Yabuuchi

Novartis Pharma: Tokyo, JP

2000-04-01 to 2005-09-30 (Business division (Cardiovascular))
Employment
Source: Self-asserted source
Mihoko Yabuuchi

Education and qualifications (3)

Juntendo University: Tokyo, JP

(Graduate school of Medicine)
Education
Source: Self-asserted source
Mihoko Yabuuchi

Aoyama Gakuin University: Tokyo, JP

2017-04-01 to 2019-03-31 | M.B.A. (International Management)
Education
Source: Self-asserted source
Mihoko Yabuuchi

Osaka University: Osaka, JP

1998-04-01 to 2000-03-31 | Bachelor of Economics (Economics)
Education
Source: Self-asserted source
Mihoko Yabuuchi

Works (4)

Safety risks of interstitial lung disease upon real-world usage of Janus kinase inhibitors and biologics for patients with autoimmune diseases: epidemiological study using nationwide electronic medical record database in Japan

Immunological Medicine
2024-07-02 | Journal article
DOI: 10.1080/25785826.2024.2311763
Contributors: Mihoko Yabuuchi; Kazuhito Yokoyama
Source: check_circle
Crossref

Evaluation of the Pharmaceutical Life Cycle Management in the Pharmaceutical Prescription Drug for Hypertension Therapy - Evidence from the National Database Opendata -

International Management Review
2019-03 | Journal article
Contributors: Mihoko Yabuuchi
Source: Self-asserted source
Mihoko Yabuuchi

(In Japanese) 気管支喘息に対するサルメテロールキシナホ酸塩酸・フルチカゾンプロピオン酸エステルドライパウダーインヘラー（アドエアRディスカスR）の使用成績調査（最終報告））

アレルギー免疫
2012 | Journal article
Contributors: Mihoko Yabuuchi
Source: Self-asserted source
Mihoko Yabuuchi

（In Japanese）下肢整形外科手術施行患者に対するアリクストラR皮下注（フォンダパリヌクスナトリウム）の特定使用成績調査

臨床医薬
2012 | Journal article
Contributors: Mihoko Yabuuchi
Source: Self-asserted source
Mihoko Yabuuchi

Peer review (1 review for 1 publication/grant)

Review activity for PLoS medicine. (1)
How many people are using ORCID?